nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—Tamsulosin—HTR7—Parkinson's disease	0.0137	0.132	CrCbGaD
Bevantolol—Tamsulosin—DRD3—Parkinson's disease	0.0129	0.124	CrCbGaD
Bevantolol—Tamsulosin—HTR1A—Parkinson's disease	0.0105	0.101	CrCbGaD
Bevantolol—Tamsulosin—DRD2—Parkinson's disease	0.00892	0.0857	CrCbGaD
Bevantolol—Ranolazine—CYP2D6—Parkinson's disease	0.00655	0.0629	CrCbGaD
Bevantolol—Tamsulosin—CYP2D6—Parkinson's disease	0.00631	0.0606	CrCbGaD
Bevantolol—Bisoprolol—CYP2D6—Parkinson's disease	0.00609	0.0585	CrCbGaD
Bevantolol—Metoprolol—CYP2D6—Parkinson's disease	0.00487	0.0468	CrCbGaD
Bevantolol—Carvedilol—CYP2E1—Parkinson's disease	0.0044	0.0423	CrCbGaD
Bevantolol—Propranolol—HTR1A—Parkinson's disease	0.0041	0.0393	CrCbGaD
Bevantolol—Verapamil—CYP2D6—Parkinson's disease	0.00373	0.0358	CrCbGaD
Bevantolol—Propafenone—CYP2D6—Parkinson's disease	0.00359	0.0345	CrCbGaD
Bevantolol—Metoprolol—ABCB1—Parkinson's disease	0.00348	0.0334	CrCbGaD
Bevantolol—Carvedilol—CYP2D6—Parkinson's disease	0.00323	0.031	CrCbGaD
Bevantolol—Verapamil—ABCB1—Parkinson's disease	0.00266	0.0255	CrCbGaD
Bevantolol—Propafenone—ABCB1—Parkinson's disease	0.00256	0.0246	CrCbGaD
Bevantolol—Propranolol—CYP2D6—Parkinson's disease	0.00246	0.0236	CrCbGaD
Bevantolol—Carvedilol—ABCB1—Parkinson's disease	0.00231	0.0222	CrCbGaD
Bevantolol—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00178	0.00198	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00177	0.00198	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00176	0.00197	CbGpPWpGaD
Bevantolol—Propranolol—ABCB1—Parkinson's disease	0.00175	0.0169	CrCbGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00174	0.00194	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00174	0.00194	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—GRM5—Parkinson's disease	0.00172	0.00192	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.0017	0.0019	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.0017	0.0019	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—EDN1—Parkinson's disease	0.0017	0.0019	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00166	0.00186	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00166	0.00185	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00164	0.00183	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00164	0.00183	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00164	0.00183	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.00162	0.00181	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GPR37—Parkinson's disease	0.00161	0.00179	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—DGKQ—Parkinson's disease	0.00161	0.00179	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00161	0.00179	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00156	0.00175	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00155	0.00174	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	0.00154	0.00172	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.00153	0.00171	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00152	0.0017	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	0.00151	0.00169	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.00151	0.00168	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	0.00151	0.00168	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00149	0.00166	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00149	0.00166	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.00148	0.00165	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.00147	0.00164	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00147	0.00164	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.00146	0.00163	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00146	0.00163	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00145	0.00162	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.00143	0.0016	CbGpPWpGaD
Bevantolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00142	0.00159	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.00142	0.00158	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.00141	0.00157	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00141	0.00157	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00141	0.00157	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00139	0.00155	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00139	0.00155	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.00139	0.00155	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.00138	0.00154	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00136	0.00152	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.00135	0.00151	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GRK5—Parkinson's disease	0.00134	0.0015	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00133	0.00148	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.00132	0.00148	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.00132	0.00148	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.00132	0.00147	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.00129	0.00144	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.00129	0.00144	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00129	0.00144	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.00128	0.00143	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—HTR1A—Parkinson's disease	0.00127	0.00141	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00126	0.00141	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.00125	0.0014	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—TAC1—Parkinson's disease	0.00125	0.00139	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—DRD1—Parkinson's disease	0.00122	0.00136	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GRK5—Parkinson's disease	0.00122	0.00136	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00122	0.00136	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GRM4—Parkinson's disease	0.0012	0.00134	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0012	0.00134	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00119	0.00133	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—DRD3—Parkinson's disease	0.00118	0.00132	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.00117	0.00131	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.00117	0.00131	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.00117	0.00131	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.00117	0.00131	CbGpPWpGaD
Bevantolol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00115	0.00128	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.00115	0.00128	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.00115	0.00128	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VPS35—Parkinson's disease	0.00115	0.00128	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.00115	0.00128	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PENK—Parkinson's disease	0.00114	0.00127	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00113	0.00126	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GRM4—Parkinson's disease	0.00109	0.00122	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.00109	0.00121	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00107	0.0012	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—HTR7—Parkinson's disease	0.00107	0.0012	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—DRD2—Parkinson's disease	0.00107	0.0012	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.00106	0.00119	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.00106	0.00118	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00105	0.00117	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PDYN—Parkinson's disease	0.00104	0.00116	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.00104	0.00116	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PENK—Parkinson's disease	0.00104	0.00116	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00102	0.00114	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000997	0.00111	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000985	0.0011	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GRM5—Parkinson's disease	0.00097	0.00108	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GPR37—Parkinson's disease	0.000949	0.00106	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—DGKQ—Parkinson's disease	0.000949	0.00106	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PDYN—Parkinson's disease	0.000947	0.00106	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	0.000938	0.00105	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000927	0.00103	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000925	0.00103	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	0.000917	0.00102	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000907	0.00101	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000905	0.00101	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	0.000889	0.000992	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000884	0.000987	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GRM5—Parkinson's disease	0.00088	0.000983	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000871	0.000972	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	0.00087	0.000971	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000868	0.000969	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000865	0.000965	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—EDN1—Parkinson's disease	0.000857	0.000957	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000854	0.000953	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000852	0.000951	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000835	0.000932	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000827	0.000923	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000824	0.00092	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000809	0.000903	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000803	0.000896	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	0.000797	0.00089	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	0.000791	0.000883	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000785	0.000877	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	0.00078	0.000871	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	0.000775	0.000865	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	0.000773	0.000863	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000772	0.000862	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RIT2—Parkinson's disease	0.000759	0.000847	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	0.000758	0.000847	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	0.000756	0.000844	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	0.000756	0.000844	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000755	0.000843	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	0.000751	0.000838	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—HTR2A—Parkinson's disease	0.00075	0.000837	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000749	0.000836	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000748	0.000835	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000748	0.000835	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	0.00074	0.000825	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	0.00074	0.000825	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	0.000735	0.00082	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000732	0.000817	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000732	0.000817	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GRK5—Parkinson's disease	0.000719	0.000803	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000715	0.000798	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—TAC1—Parkinson's disease	0.000704	0.000786	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000701	0.000783	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	0.000691	0.000772	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000691	0.000771	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000686	0.000766	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	0.000679	0.000758	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	0.000679	0.000758	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	0.000676	0.000755	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000669	0.000747	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	0.000664	0.000742	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	0.000664	0.000742	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	0.00065	0.000726	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	0.00065	0.000725	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	0.000645	0.00072	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	0.000643	0.000718	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	0.00064	0.000714	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	0.000636	0.00071	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	0.000629	0.000702	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	0.000627	0.0007	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000625	0.000697	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	0.000612	0.000683	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	0.000612	0.000683	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	0.000608	0.000678	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000605	0.000675	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000605	0.000675	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000599	0.000668	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000586	0.000654	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000567	0.000633	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	0.000564	0.000629	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	0.000559	0.000624	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	0.000551	0.000615	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	0.000549	0.000613	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	0.000549	0.000613	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000547	0.00061	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	0.000544	0.000607	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000535	0.000597	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	0.000532	0.000594	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	0.000526	0.000587	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000524	0.000585	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	0.00052	0.000581	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000512	0.000572	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	0.000504	0.000563	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	0.000493	0.000551	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000484	0.000541	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	0.000477	0.000532	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000476	0.000531	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	0.000474	0.000529	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	0.000467	0.000521	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	0.000466	0.000521	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000465	0.000519	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	0.000464	0.000518	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000462	0.000515	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	0.000458	0.000511	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	0.000457	0.00051	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	0.000456	0.000509	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	0.000448	0.0005	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	0.000444	0.000495	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000442	0.000494	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	0.00044	0.000491	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	0.000434	0.000484	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000424	0.000473	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000414	0.000462	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	0.000408	0.000456	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000405	0.000452	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	0.000401	0.000448	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	0.000401	0.000448	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	0.000392	0.000438	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	0.000392	0.000438	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	0.000386	0.000431	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000385	0.00043	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000384	0.000428	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	0.000378	0.000422	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	0.000371	0.000414	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	0.000359	0.000401	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	0.000336	0.000375	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000335	0.000374	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	0.000329	0.000367	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	0.000325	0.000363	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	0.000325	0.000362	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	0.000325	0.000362	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	0.000321	0.000359	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	0.000318	0.000355	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	0.000314	0.000351	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	0.000295	0.000329	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	0.000289	0.000322	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	0.000281	0.000314	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	0.000275	0.000307	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	0.000272	0.000304	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	0.000263	0.000294	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	0.000261	0.000292	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	0.00026	0.00029	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	0.000256	0.000285	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	0.000239	0.000267	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	0.000227	0.000254	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	0.000223	0.000249	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	0.000218	0.000244	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	0.000211	0.000236	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—INS—Parkinson's disease	0.000181	0.000202	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	0.000166	0.000185	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	0.000165	0.000184	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	0.000163	0.000181	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	0.000161	0.00018	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	0.000153	0.00017	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	0.000149	0.000167	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	0.000134	0.00015	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	0.000134	0.000149	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	0.000124	0.000138	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	9.75e-05	0.000109	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	9.54e-05	0.000106	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	7.89e-05	8.81e-05	CbGpPWpGaD
